Sep 25, 2012 | News
Marchmont News 21 September 2012 Maxwell Biotech, a Russian VC fund, has decided to invest in Eleventa, a start-up established earlier this year to develop and commercialize drugs to treat bronchial asthma and some other respiratory allergic diseases, the official...
